Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
Launched by M.D. ANDERSON CANCER CENTER · Mar 2, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The AIRTECH Study is a clinical trial that looks at how walking and sleeping habits can affect recovery for patients undergoing surgery for lung cancer. Researchers want to understand if getting up and walking shortly after surgery can lead to fewer complications and better overall recovery. By tracking how much patients walk, the study aims to find ways to help improve patients' health and quality of life after surgery.
To participate in this study, you need to be at least 18 years old, speak English, and be able to walk on your own before the surgery. You’ll need to have a smartphone, be willing to use a specific app to track your steps, and have a good internet connection. The study is currently looking for participants, and while it aims to help improve recovery for lung cancer surgery patients, some individuals may not be eligible due to medical conditions or other factors. If you join, you can expect to help contribute valuable information that could improve outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • English speaking
- • Ambulatory preoperatively
- • Patients undergoing at least a lobectomy
- • Must own a smart phone and be willing to install the Fitbit application (App)
- • Adequate internet connection via wifi or wireless network connection with smartphone
- • Patients who are not already using a wearable device to track daily steps
- Exclusion Criteria:
- • Medical, psychiatric, cognitive or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study.
- • Cannot maintain activity monitor in place at the time of consent
- • Pregnant patients
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Garrett L Walsh
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials